103 related articles for article (PubMed ID: 28101577)
1. Viscumins functionally modulate cell motility-associated gene expression.
Schötterl S; Hübner M; Armento A; Veninga V; Wirsik NM; Bernatz S; Lentzen H; Mittelbronn M; Naumann U
Int J Oncol; 2017 Feb; 50(2):684-696. PubMed ID: 28101577
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiles of different breast cancer cells compared with their responsiveness to fermented mistletoe (Viscum album L.) extracts Iscador from oak (Quercus), pine (Pinus), white fir (Abies) and apple tree (Malus) in vitro.
Eggenschwiler J; Patrignani A; Wagner U; Rehrauer H; Schlapbach R; Rist L; Ramos MH; Viviani A
Arzneimittelforschung; 2006 Jun; 56(6A):483-96. PubMed ID: 16927530
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative potential from aqueous Viscum album L. preparations and their main constituents in comparison with ricin and purothionin on human cancer cells.
Felenda JE; Turek C; Stintzing FC
J Ethnopharmacol; 2019 May; 236():100-107. PubMed ID: 30840914
[TBL] [Abstract][Full Text] [Related]
4. Gene network analysis on the effect of Viscum album var. coloratum in T cells stimulated with anti-CD3/CD28 antibodies.
Lyu SY; Park WB
Arch Pharm Res; 2011 Oct; 34(10):1735-49. PubMed ID: 22076774
[TBL] [Abstract][Full Text] [Related]
5. MAP kinase-interacting kinase 1 regulates SMAD2-dependent TGF-β signaling pathway in human glioblastoma.
Grzmil M; Morin P; Lino MM; Merlo A; Frank S; Wang Y; Moncayo G; Hemmings BA
Cancer Res; 2011 Mar; 71(6):2392-402. PubMed ID: 21406405
[TBL] [Abstract][Full Text] [Related]
6. Impact of Mistletoe Triterpene Acids on the Uptake of Mistletoe Lectin by Cultured Tumor Cells.
Mulsow K; Enzlein T; Delebinski C; Jaeger S; Seifert G; Melzig MF
PLoS One; 2016; 11(4):e0153825. PubMed ID: 27088729
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant Therapy Using Mistletoe Containing Drugs Boosts the T-Cell-Mediated Killing of Glioma Cells and Prolongs the Survival of Glioma Bearing Mice.
Schötterl S; Huber SM; Lentzen H; Mittelbronn M; Naumann U
Evid Based Complement Alternat Med; 2018; 2018():3928572. PubMed ID: 30224928
[No Abstract] [Full Text] [Related]
8. The preclinical and clinical activity of aviscumine: a potential anticancer drug.
Zwierzina H; Bergmann L; Fiebig H; Aamdal S; Schöffski P; Witthohn K; Lentzen H
Eur J Cancer; 2011 Jul; 47(10):1450-7. PubMed ID: 21482461
[TBL] [Abstract][Full Text] [Related]
9. Fermented mistletoe extract as a multimodal antitumoral agent in gliomas.
Podlech O; Harter PN; Mittelbronn M; Pöschel S; Naumann U
Evid Based Complement Alternat Med; 2012; 2012():501796. PubMed ID: 23133496
[TBL] [Abstract][Full Text] [Related]
10. Smad4 silencing in pancreatic cancer cell lines using stable RNA interference and gene expression profiles induced by transforming growth factor-beta.
Jazag A; Ijichi H; Kanai F; Imamura T; Guleng B; Ohta M; Imamura J; Tanaka Y; Tateishi K; Ikenoue T; Kawakami T; Arakawa Y; Miyagishi M; Taira K; Kawabe T; Omata M
Oncogene; 2005 Jan; 24(4):662-71. PubMed ID: 15592526
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of the sensitivity of lymphoblastoid and transformed monocytic cell lines to the cytotoxic effects of Viscum album extracts of different origin.
Duong Van Huyen JP; Delignat S; Kazatchkine MD; Kaveri SV
Chemotherapy; 2003 Dec; 49(6):298-302. PubMed ID: 14671430
[TBL] [Abstract][Full Text] [Related]
12. Viscotoxins, mistletoe lectins and their isoforms in mistletoe (Viscum album L.) extracts Iscador.
Urech K; Schaller G; Jäggy C
Arzneimittelforschung; 2006 Jun; 56(6A):428-34. PubMed ID: 16927522
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis-inducing properties of Viscum album L. extracts from different host trees, correlate with their content of toxic mistletoe lectins.
Büssing A; Schietzel M
Anticancer Res; 1999; 19(1A):23-8. PubMed ID: 10226520
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic effects of mistletoe (Viscum album L.) in head and neck squamous cell carcinoma cell lines.
Klingbeil MF; Xavier FC; Sardinha LR; Severino P; Mathor MB; Rodrigues RV; Pinto DS
Oncol Rep; 2013 Nov; 30(5):2316-22. PubMed ID: 24026291
[TBL] [Abstract][Full Text] [Related]
15. Polysaccharides from fresh Viscum album L. berry extract and their interaction with Viscum album agglutinin I.
Edlund U; Hensel A; Fröse D; Pfüller U; Scheffler A
Arzneimittelforschung; 2000 Jul; 50(7):645-51. PubMed ID: 10965423
[TBL] [Abstract][Full Text] [Related]
16. Mistletoe (viscum album) lectins as cytokine inducers and immunoadjuvant in tumor therapy. A review.
Bocci V
J Biol Regul Homeost Agents; 1993; 7(1):1-6. PubMed ID: 8346712
[TBL] [Abstract][Full Text] [Related]
17. Interaction of a standardized mistletoe (Viscum album) preparation with antitumor effects of Trastuzumab in vitro.
Weissenstein U; Kunz M; Urech K; Regueiro U; Baumgartner S
BMC Complement Altern Med; 2016 Aug; 16():271. PubMed ID: 27491866
[TBL] [Abstract][Full Text] [Related]
18. The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer.
Yamamura S; Matsumura N; Mandai M; Huang Z; Oura T; Baba T; Hamanishi J; Yamaguchi K; Kang HS; Okamoto T; Abiko K; Mori S; Murphy SK; Konishi I
Int J Cancer; 2012 Jan; 130(1):20-8. PubMed ID: 21503873
[TBL] [Abstract][Full Text] [Related]
19. Absence of tumor growth stimulation in a panel of 16 human tumor cell lines by mistletoe extracts in vitro.
Maier G; Fiebig HH
Anticancer Drugs; 2002 Apr; 13(4):373-9. PubMed ID: 11984083
[TBL] [Abstract][Full Text] [Related]
20. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
